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Abstract
Rationale: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by abnormal vessel
growth that results in telangiectasias and arteriovenousmalformations (AVMs) in the skin, mucosa, and viscera. Up to 30%of patients
with HHT exhibit pulmonary AVMs (PAVMs), clinically manifesting as right-to-left shunting and hypoxemia.
PatientConcerns:We report an unusual and novel case of a patient with HHTwho lacked clinical sequelae of portal hypertension
but presented to clinic with hypoxemia without dyspnea.
Diagnoses: Diagnostic workup revealed noncardiac right-to-left shunting due to hepatopulmonary syndrome (HPS) from HHT-
induced portal hypertension rather than PAVMs. The diagnosis was confirmed by the absence of PAVMs on chest computed
tomography and evidence of elevated portal pressures as noted by the presence of small esophageal varices on upper endoscopy
and histologic findings on liver biopsy.
Intervention: Due to the patient’s mild symptoms, no further intervention was required. He was closely followed up in the
outpatient setting for changes in symptoms and underwent annual screening for development of PAVMs.
Outcomes: The patient continues to do well clinically. He has not experienced worsening hypoxemia or dyspnea and has not
developed PAVMs.
Lessons: Given that management of hypoxemia in HPS drastically differs from that of hypoxemia due to PAVMs, this case
demonstrates the importance of evaluating HHT patients for HPS if they exhibit impaired oxygenation and noncardiac right-to-
leftshunting in the setting of hepatic arteriovenous shunting.
Abbreviations: A-a gradient= alveolar-arterial gradient, AVM= arteriovenousmalformation, BNP=B-type natriuretic peptide, CT
= computed tomogram, HHT = hereditary hemorrhagic telangiectasia, HPS = hepatopulmonary syndrome, PAVM = pulmonary
arteriovenous malformation, RV = right ventricular.
Keywords: alveolar-arterial gradient, hepatopulmonary syndrome, hereditary hemorrhagic telangiectasia, pulmonary arteriove-
nous malformation, pulmonary circulation1. Introduction
Hepatopulmonary syndrome (HPS), a syndrome characterized
by hypoxemia resulting from diffusion impairment due to
intrapulmonary dilations, is a well-recognized complication of
portal hypertension and most commonly occurs in the context of
liver cirrhosis.[1] Less commonly, HPS may also occur in theEditor: N/A.
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1setting of noncirrhotic portal hypertension. We describe for the
first time a case of HPS arising as a consequence of hereditary
hemorrhagic telangiectasia (HHT), a multisystem disorder
characterized by telangiectasias, arteriovenous malformations
(AVMs), and recurrent nosebleeds. The patient developed AVMs
in the liver, leading to noncirrhotic portal hypertension and
HPS.
2. Informed consent
Given that this is a case report, an ethics committee approval was
not required. We did not use patient identifiers and maintained
the anonymity of our patient. The patient verbally consented to
have this case reported.
3. Case description
A 60-year-old male with a history of newly diagnosed HHT
presented for evaluation of right-to-left shunting seen on
screening bubble contrast echocardiogram. The diagnosis of
HHT was discovered incidentally a few months prior (Fig. 1). At
that time, he underwent hemicolectomy and chemotherapy for
colon cancer and developed persistent abdominal pain and fevers
post-chemotherapy. An extensive workup was performed,
Incidental finding of 
small esophageal varices 
on upper endoscopy 
indicate portal 
hypertension
Abdominal MRI reveals 
vascular malformation 
with  hepatic 
arteriovenous shunting 
Family history and 




Patient presents to 
clinic with 
hypoxemia
Blood gas and echocardiogram 
reveal oxygen impairment and 





Figure 1. Timeline of patient presentation and diagnosis.
Figure 2. Magnetic resonance imaging of the abdomen demonstrating hepatic artery to portal vein shunting. (A) Irregular liver density and enlarged braches of right
hepatic artery. (B) Enlarged portal vein and atrophy of right lobe of liver.
Table 1






Multiple, at characteristic sites:
lips, oral cavity, nose, fingers
3. Vascular malformations
∗
GI, pulmonary, hepatic, cerebral, spinal
4. Family history† First degree relative with HHT
Definite diagnosis: 3 criteria present. Possible diagnosis: 2 criteria present. Unlikely diagnosis: less
than 2 criteria present.
HHT = hereditary hemorrhagic telangiectasia.
∗
Criteria that our patient met.
† Unclear if our patient met this criteria.
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esophageal varices. To further evaluate the etiology of the
varices, magnetic resonance imaging of the abdomen was
performed; this revealed mild splenomegaly, multiple hepatic
AVMs with significant abnormal hepatic artery to portal venous
shunting (Fig. 2A), and atrophy of the right lobe of the liver
(Fig. 2B). A liver biopsy was subsequently performed and
revealed focal sinusoidal dilation with nodular regenerative
changes and ectopic portal vein branches without any evidence of
fibrosis, consistent with noncirrhotic portal hypertension from
hepatic AVMs. A more extensive review of his medical history
revealed that he and several first-degree family members had a
history of recurrent epistaxis. In addition, he also had physical
examination findings of facial telangiectasias. Based on these
criteria, a definite diagnosis of HHT was made according to
Curaçao criteria (Table 1).[2] Genetic sequencing testing for
ENG, ACVRL1, and SMAD4 was negative and deletion/
duplication testing for ENG and ACVRL1 was negative as well.2At the time of evaluation, the patient had no symptoms of
dyspnea, exercise intolerance, or hemoptysis. He also denied any
neurologic symptoms. His vital signs were as follows: tempera-
ture of 98.2F, blood pressure of 163/97 mm Hg, heart rate of
70/min, and oxygen saturation of 93% on room air. Physical
Figure 3. Noncontrasted computed tomography scan of the chest showing absence of pulmonary arteriovenous malformations and normal lung parenchyma.
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Head and neck exam were significant for telangiectasias on his
nose, while no telangiectasias were present on his lips or in the
oral cavity. Examination of the heart, lungs, and neurologic
system were normal. An echocardiogram with bubble study was
performed to evaluate for pulmonary AVMs. This revealed a
small noncardiac right-to-left shunt. Other echocardiographic
findings included a normal left ventricular systolic and diastolic
function and normal right atrial and right ventricular (RV) size.
RV systolic function and estimated RV systolic pressure were
normal. The presence of pulmonary AVMs was ruled out
through multiple contrasted chest computed tomograms (CTs).
In addition, chest CTs did not provide any evidence of
parenchymal or airway disease (Fig. 3). Pulmonary function
testing revealed normal spirometry and lung volumes. Lung
perfusion scanning and B-type natriuretic peptide (BNP) level
were normal. Due to known portal hypertension from hepatic
AVMs and oximetry of 93% on room air, an arterial blood gas
was ordered. This revealed an elevated alveolar-arterial (A-a)
gradient of 18 mm Hg which was later repeated and revealed a
gradient of 38 mm Hg (expected A-a gradient for his age was 15
mm Hg). Given the triad of portal hypertension, right-to-left
shunt, and increased A-a gradient (Table 2), a diagnosis of
hepatopulmonary syndrome (HPS) was made.[3]
4. Discussion
HHT is an autosomal dominant disorder characterized by
abnormal vessel growth that results in telangiectasias and AVMsTable 2
Clinical criteria for hepatopulmonary syndrome.
Clinical criteria Features present
Portal hypertension Noncirrhotic portal
Oxygenation defect: partial pressure of oxygen<80mm Hg
or A-a gradient ≥ 15mm Hg while breathing ambient air
Oxygen saturation
Pulmonary vascular dilatation Noncardiac right to
A-a gradient= alveolar-arterial gradient.
3in the skin, mucosa, and viscera. Patients with HHT can have
AVMs in the pulmonary, cerebral, gastrointestinal, and hepatic
vasculature. The risk for pulmonary AVMs is as high as 30%.[4,5]
While all patients with HHT should be screened for pulmonary
AVMs, in this report we highlight the importance of considering
other, less common pulmonary complications in HHT patients.
Our patient most likely developed portal hypertension because of
hepatic AVMs, which put him at risk for HPS as well as
portopulmonary hypertension. The latter, however, was ruled
out by echocardiography and BNP level measurement, both of
which were normal. In addition, pulmonary hypertension would
be unlikely to cause noncardiac right to left shunting. The patient
was noted to have an increased A-a gradient on 2 separate
occasions. This finding, combined with exclusion of parenchymal
pulmonary and airway pathologies by chest CT and pulmonary
function testing, makes the diagnosis of HPS in this patient robust
and reproducible. To the best of our knowledge, this is the first
report of HPS in a patient with HHT.
The urgency in identifying pulmonary AVMs derives from the
potential for detrimental events due to direct communication of
venous blood into the systemic circulation; these include
cerebrovascular accidents from paradoxical emboli, septic
emboli, and brain abscesses. Regardless of symptoms, emboliza-
tion of the feeding vessel should be attempted.[6–8] While the
presence of pulmonary AVMs requires an aggressive manage-
ment approach, other pulmonary pathology should be pursued
when appropriate. Hepatic AVMs, if draining into the portal
vein, can cause significant noncirrhotic portal hypertension, as
was the case in our patient.[9,10] This puts patients at risk forin this patient
hypertension evidenced by esophageal varices, splenomegaly, and liver biopsy findings
93% on room air; initial A-a gradient of 18 mm Hg and repeat gradient of 35 mm Hg
left shunting seen on contrasted echocardiography
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manifests as hypoxemia and/or increased A-a gradient (as noted
in our patient, explaining the right-to-left shunting noted on
echocardiogram). Though the pathogenesis of HPS is poorly
understood, commonly accepted mechanisms include intra-
pulmonary dilated vascular abnormalities, diffusion-perfusion
imbalance, and hyperdynamic circulation of the pulmonary
bed.[1,11] Experimental studies implicate an increase in vasoactive
substances as a result of portal hypertension as a potential cause
of HPS.[12,13] A recent study indicated that polymorphisms in
genes involved in the regulation of angiogenesis may be
associated with HPS development.[14] Of note, one of the
candidate genes was ENG, mutations of which are associated
with HHT development.[15] However, our patient did not exhibit
any mutations in ENG. The observation that genetic abnormali-
ties in genes involved in the regulation of angiogenesis represent
potential risk factors for HPS development, and the fact that
HHT is due to abnormal blood vessel development suggest that
there may be a common link between HPS and HHT. This needs
further evaluation in future studies.
Due to our patient’s lack of subjective symptoms, mild
hypoxemia, and the absence of pulmonary AVMs on CT
imaging, no specific interventions were made. He is currently
being observed, with annual screenings for new symptoms,
worsening hypoxemia, and pulmonary AVMs.5. Conclusion
This novel case emphasizes that while suspicion for pulmonary
AVMs should be high in HHT patients with right to left shunting
and hypoxemia or increased A-a gradient, HPS from portal
hypertension should be considered in the differential diagnosis if
the patient exhibits signs of impaired oxygenation and has
clinical findings or data consistent with portal hypertension.Author contributions
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